Looking for oncotype dx login? Get direct access to oncotype dx login through official links provided below.
Last updated at November 11th, 2020We would like to show you a description here but the site won’t allow us.
Status : OnlineThe only genomic test proven to predict a patient’s individual benefit from chemotherapy. For patients with early-stage, ER-positive, HER2-negative, node negative, and node-positive (1-3) breast cancer, the Oncotype DX Breast Recurrence Score quantifies the risk of distant recurrence and the likelihood of chemotherapy benefit.
Status : OnlineOrdering an Oncotype DX test and receiving the results is a straightforward process. Simply follow these 4 steps. STEP 1 of 4. Get specimen kits Genomic Health provides a specimen transportation kit box for each patient’s tissue sample. ... Simply login to the online physician portal ...
Status : OnlineThe Oncotype DX invasive breast cancer results are typically reported within 7 - 10 days after the sample is received. Reports can be delivered by fax or secure online transfer to the treating physician, submitting pathologist and/or other authorized healthcare providers.
Status : OnlineSTEP 1 - Get specimen kits. Exact Sciences provides a specimen transportation kit box for each patient’s tissue sample. Request specimen transportation kit boxes by contacting Customer Service at 866-ONCOTYPE (866-662-6897) or email us with your information.. Kit orders usually arrive to you within 48 hours.
Status : OnlineThe Oncotype DX GPS assay has been developed and studied in over 5,000 patients. 1-14 The results from the assay refine risk assessment, help guide treatment decisions, and potentially impact patient quality of life. For example, the results might give a low- or favorable intermediate-risk patient the additional confidence he needs to pursue ...
Status : OnlineThe Oncotype DX test is a genomic test that analyzes the activity of a group of genes that can affect how a cancer is likely to behave and respond to treatment. The Oncotype DX is used in two ways: to help doctors figure out a woman’s risk of early-stage, estrogen-receptor-positive breast cancer coming back (recurrence), as well as how likely ...
Status : OnlineOncotype DX is the most common tumor profiling test in the U.S. Other tumor profiling tests (such as MammaPrint ® and PAM50 (also called Prosigna ®)) are available. Oncotype DX is the only one used in breast cancer staging. Oncotype DX testing. Oncotype DX tests a sample of the tumor (removed during a biopsy or surgery) for a group of 21 genes.
Status : OnlineTroubleshoot
Recently Viewed
Most Viewed
© logins-db.web.app 2020. All rights reserved.